<h1>Markets rally as banking, pharma lead on foreign inflows and biotech export rules tightening affecting cross-border collaborations</h1> Benchmark equity indices rose on strong gains in banking and pharmaceutical stocks, driven by foreign institutional inflows and government moves to invite private-sector professionals to lead a major state-owned bank. Markets reacted positively to revived U.S. biotechnology security legislation restricting ties with flagged foreign firms, which benefits domestic contract development and manufacturing organizations; this signals heightened regulatory scrutiny of cross-border biotech collaboration. The developments implicate corporate governance shifts in state entities, potential changes to foreign investment and trade compliance obligations for pharma firms, and continued market sensitivity to geopolitical regulatory measures affecting sectoral valuations.